Israel's prime minister Netanyahu said the "alliance between the left and radical Islamism" is destroying France, Belgium, Italy and Spain, is now attempting to destroy the United States, and could also destroy Israel.

Pfizer said an experimental antibody‑drug conjugate, sigvotatug vedotin, failed to meet the primary endpoint in a trial of unresectable advanced lung cancer, showing no overall survival benefit versus chemotherapy. In a post‑hoc analysis presented at ESMO on Sunday, Pfizer reported that a subgroup of less‑heavily pretreated patients receiving the drug in combination showed survival more than two months longer than the chemotherapy control. Pfizer, which acquired the asset when it bought Seagen for $43 bln and had expected it to be a first‑in‑class product, said it will continue to pursue development and combination strategies.

Russia's presidential aide USHAKOV said Russia is prepared to resume tripartite Russia–US–Ukraine talks after Nov. 4.